Please login to the form below

Not currently logged in
Email:
Password:

Roche Diagnostics

This page shows the latest Roche Diagnostics news and features for those working in and with pharma, biotech and healthcare.

Roche buys GenMark for $1.8bn to bolster diagnostics portfolio

Roche buys GenMark for $1.8bn to bolster diagnostics portfolio

Swiss pharma company Roche has entered into a definitive merger agreement to acquire GenMark Diagnostics for approximately $1.8bn. ... Thomas Schinecker, chief executive officer of Roche Diagnostics.

Latest news

More from news
Approximately 6 fully matching, plus 60 partially matching documents found.

Latest Intelligence

  • Switzerland: a life sciences hub Switzerland: a life sciences hub

    The FDA has just granted Roche emergency use authorisation (EUA) for its new test to detect the virus that causes the coronavirus. ... This test emerges from Roche’s diagnostics division, also headquartered in Switzerland.

  • Pharma deals in August 2015 Pharma deals in August 2015

    This situation occurred when Genentech/Roche elected not to go further with their option to acquire the epigenetics drug discovery company, Constellation Pharmaceuticals. ... Exclusive global licence. 452. GeneWEAVE. Roche. Innovative clinical

  • Diagnostics are rising up the pharma value chain Diagnostics are rising up the pharma value chain

    Pharma interview: Anssi Pulkkinen from Roche Diagnostics, Finland on the increasing prominence of diagnostics. ... lung cancer, which was backed together with Roche Diagnostics' cobas EGFR Mutation Test.

  • Interview: AstraZeneca's Susan Galbraith Interview: AstraZeneca's Susan Galbraith

    Drug discovery and development is a team sport. You can't do it really well without partnerships with academia, biotech and diagnostics companies. ... AZ is still leaving the development of companion diagnostics to external experts, however, including a

  • Deal Watch table for April 2014 Deal Watch table for April 2014

    570. Oryzon/ Roche (pRED). Early stage drug research pact. Oncology - LSD1 inhibitors, Orphan cancer blocker ORY-1001 (p1/2a for acute myeloid leukaemia). ... 521+. Iquum/ Roche. Acquisition. Molecular Diagnostics - Laboratory-in-a-tube (Liat) System. 450

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Atlas Genetics appoints Jeffery Luber as CEO Atlas Genetics appoints Jeffery Luber as CEO

    Prior to his new role at Atlas, Luber most recently led the return to growth and sale of Good Start Genetics to Invitae Corp, producing strategic partnerships with Roche Diagnostics and ... Amazon. Dr John Clarkson, founding CEO, Atlas Genetics, said:

  • Pegasus expands pharma and life sciences senior team Pegasus expands pharma and life sciences senior team

    Prior to this, Osborn worked at LEO Pharma, Roche Diagnostics and Weber Shandwick.

  • MDxHealth creates new global commercial team MDxHealth creates new global commercial team

    Skinner has over 30 years of international experience in senior sales and marketing positions with in-vitro diagnostic firms including Boehringer Mannheim (now Roche Diagnostics), Human Diagnostica, Bard Diagnostic Science, and ... Meanwhile, Dr

  • Roche's Silvia Ayyoubi retires Roche's Silvia Ayyoubi retires

    Ayyoubi will be succeeded by Cristina Wilbur, who is currently head of human resources for Roche's diagnostics division, based in Basel. ... She first joined the company's US operations in 2002 and from 2006 until 2010 was head of human resources for

  • Crescendo Biologics appoints Peter Pack as CEO Crescendo Biologics appoints Peter Pack as CEO

    He has also previously served on the board of Signature Diagnostics AG before its sale to Roche in February 2015. .

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

  • Winners of the HSJ Partnership Awards 2019 unveiled Winners of the HSJ Partnership Awards 2019 unveiled

    Best Healthcare Provider Partnership - Roche Diagnostics and Oxford AHSN. Best Not for Profit Working in Partnership with the NHS - Breast Cancer Care, NHS Trusts and Health Boards.

  • Mind+Matter Mind+Matter

    Biocryst, Biogen,  Biomarin, Bio-Oil, Boehringer Ingelheim,  Cryoport, Colgate Palmolive, CSL Behring, Eiger BioPharmaceuticals, EIT Health, Elanco, GSK, Holland &Barrett,  HealthforAnimals, Lloyds Pharmacy, Novo Nordisk, Raisio, Roche

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

Want to give perfect client service? Tough luck, you’re human
In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....

Infographics